PUMA BIOTECHNOLOGY INC

PBYINASDAQ • USD
7.01 USD
↘ 0.33 (4.50%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

PUMA BIOTECHNOLOGY INC (PBYI) trades at $7.01 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone and a bullish Golden Cross on the moving averages. Valuation metrics suggest PBYI is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$7.28
High?$7.32
Low?$6.93
Prev. Close?$7.34
Volume?280.7K
Avg. Volume?432.9K
VWAP?$7.07
Rel. Volume?0.65x
Bid / Ask
Bid?$7.00 × 100
Ask?$7.04 × 100
Spread?$0.04
Midpoint?$7.02
Valuation & Ratios
Market Cap?379.5M
Shares Out?51.7M
Float?39.2M
Float %?75.9%
P/E Ratio?15.92
P/B Ratio?2.59
EPS?$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Employees
179
Market Cap
379.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2012-03-21
Address
10880 WILSHIRE BLVD.
LOS ANGELES, CA
Phone: (424) 248-6500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
50
Short Sent.?
53
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.54Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.97%High
Short Interest?4.3M
Days to Cover?11.5
Free Float39.2M
Avg Daily Volume373.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.03Strong
Quick Ratio?2.81Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
78
15.9CHEAP▾
P/B?
Peers
50
S&P
63
2.59CHEAP▾
P/S?
Peers
100
S&P
76
1.64CHEAP▾
P/FCF?
Peers
100
S&P
93
8.3CHEAP▾
EV/EBITDA?
Peers
100
S&P
85
9.3CHEAP▾
EV/Sales?
Peers
100
S&P
84
1.46CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
58
16.3%STRONG▾
ROA?
Peers
50
S&P
80
11.8%STRONG▾
Cash Flow & Enterprise
FCF?$46.0M
Enterprise Value?$337.9M
Fundamentals ratios updated end of day